Y-mAbs Therapeutics, Inc.·4

Jan 22, 7:05 PM ET

PFREUNDSCHUH PETER P. 4

4 · Y-mAbs Therapeutics, Inc. · Filed Jan 22, 2025

Insider Transaction Report

Form 4
Period: 2025-01-17
PFREUNDSCHUH PETER P.
EVP, CFO and Treasurer
Transactions
  • Award

    Common Stock

    2025-01-17+31,80077,800 total
  • Award

    Employee Stock Option (right to buy)

    2025-01-17+63,50063,500 total
    Exercise: $6.16Exp: 2035-01-17Common Stock (63,500 underlying)
Footnotes (3)
  • [F1]Represents restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of Common Stock on the vesting dates of the RSU. The RSUs vest by 1/3 on each of January 17, 2026, January 17, 2027 and January 17, 2028, subject to the Reporting Person's continued service to the Issuer on each vesting date.
  • [F2]Represents stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan.
  • [F3]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2026, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Documents

1 file
  • 4
    form4-01232025_120151.xmlPrimary